Emmerich B - Search Results

1

Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia.

Hallek M, Langenmayer I, Nerl C, Knauf W, Dietzfelbinger H, Adorf D, Ostwald M, Busch R, Kuhn-Hallek I, Thiel E, Emmerich B. Hallek M, et al. Among authors: emmerich b. Blood. 1999 Mar 1;93(5):1732-7. Blood. 1999. PMID: 10029603 Free article.

2

Interferon-alpha 2b (IFN alpha) for early-phase chronic lymphocytic leukaemia with high risk for disease progression: results of a randomized multicentre study.

Langenmayer I, Nerl C, Knauf W, Dempster S, Hallek M, Adorf D, Dietzfelbinger H, Busch R, Ziegler-Heitbrock HW, Thiel E, Emmerich B. Langenmayer I, et al. Among authors: emmerich b. Br J Haematol. 1996 Aug;94(2):362-9. doi: 10.1046/j.1365-2141.1996.d01-1796.x. Br J Haematol. 1996. PMID: 8759897 Clinical Trial.

3

Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.

Hallek M, Wanders L, Ostwald M, Busch R, Senekowitsch R, Stern S, Schick HD, Kuhn-Hallek I, Emmerich B. Hallek M, et al. Among authors: emmerich b. Leuk Lymphoma. 1996 Aug;22(5-6):439-47. doi: 10.3109/10428199609054782. Leuk Lymphoma. 1996. PMID: 8882957

4

Prognostic impact of the serum levels of soluble CD23 in B-cell chronic lymphocytic leukemia.

Knauf WU, Ehlers B, Mohr B, Thiel E, Langenmayer I, Hallek M, Emmerich B, Adorf D, Nerl C, Zwingers T. Knauf WU, et al. Among authors: emmerich b. Blood. 1997 Jun 1;89(11):4241-2. Blood. 1997. PMID: 9166873 Free article. No abstract available.

5

Prognostic factors in chronic lymphocytic leukemia.

Hallek M, Kuhn-Hallek I, Emmerich B. Hallek M, et al. Among authors: emmerich b. Leukemia. 1997 Apr;11 Suppl 2:S4-13. Leukemia. 1997. PMID: 9178831 Review.

6

Serum levels of soluble CD23, but not soluble CD25, predict disease progression in early stage B-cell chronic lymphocytic leukemia.

Knauf WU, Langenmayer I, Ehlers B, Mohr B, Adorf D, Nerl CH, Hallek M, Zwingers TH, Emmerich B, Thiel E. Knauf WU, et al. Among authors: emmerich b. Leuk Lymphoma. 1997 Nov;27(5-6):523-32. doi: 10.3109/10428199709058320. Leuk Lymphoma. 1997. PMID: 9477135

7

CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells.

Buhmann R, Nolte A, Westhaus D, Emmerich B, Hallek M. Buhmann R, et al. Among authors: emmerich b. Blood. 1999 Mar 15;93(6):1992-2002. Blood. 1999. PMID: 10068672 Free article.

8

Activity of serum thymidine kinase in non-Hodgkin lymphoma: relationship to other prognostic factors.

Hallek M, Emmerich B, Strohmeyer S, Busch R, Reichle A, Senekowitsch R. Hallek M, et al. Among authors: emmerich b. Klin Wochenschr. 1988 Aug 15;66(16):718-23. doi: 10.1007/BF01726414. Klin Wochenschr. 1988. PMID: 3172680

9

Defects of beta 2-adrenergic signal transduction in chronic lymphocytic leukaemia: relationship to disease progression.

Kamp T, Liebl B, Haen E, Emmerich B, Hallek M. Kamp T, et al. Among authors: emmerich b. Eur J Clin Invest. 1997 Feb;27(2):121-7. doi: 10.1046/j.1365-2362.1997.700623.x. Eur J Clin Invest. 1997. PMID: 9061305

10

Serum thymidine kinase levels are elevated and exhibit diurnal variations in patients with advanced ovarian cancer.

Hallek M, Touitou Y, Lévi F, Mechkouri M, Bogdan A, Bailleul F, Senekowitsch R, Emmerich B. Hallek M, et al. Among authors: emmerich b. Clin Chim Acta. 1997 Nov 28;267(2):155-66. doi: 10.1016/s0009-8981(97)00132-0. Clin Chim Acta. 1997. PMID: 9469250 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters